๐น Rose Transparency Act (proposing)|Advocacy| Knowledge | Activism
Fighting for clarity in cancer care in Alaska|
Alaskan voters:๐ sign the petition!
๐๐ค๐จ๐ ๐๐ง๐๐ฃ๐จ๐ฅ๐๐ง๐๐ฃ๐๐ฎ ๐ผ๐๐ฉ ๐น โ In honor of my mom, Rose, who passed away from a sepsis infection while battling mucosal melanoma on September 3rd, ending our journey at 30 months.
I want to share a bit about her journey and how she was diagnosed. My mom, Rose, had struggled with hemorrhoids after my childbirth, so it was not unusual for her to experience them. But in 2022, her hemorrhoids lasted longer than usual. After a couple of months with no relief, she finally had a biopsy conducted in Phoenix. The results were devastating. She was diagnosed with stage 4 mucosal melanoma.
Mucosal melanoma is a rare cancer unrelated to sun exposure. It arises in the mucous membranes and is often linked to chemical exposure. Because so few cases exist, there is very little knowledge about effective treatments even though cases have been slowly increasing.
Her medical team in Alaska had limited knowledge, and it often felt like there was little interest in researching her rare cancer. We were told to meet with a specialist at a cancer center in Seattle. I traveled with her to explore whether she would qualify for TIL therapy only to learn that her insurance would not cover it. This not only cost us time but also drained our finances leaving us feeling defeated. The only takeaway was a list of clinical trials and a bit of knowledge but this was already 28 months into her journey.
Finally, during a visit follow up visit with her oncologist, urged us to get into a clinical trial as there were no more options. This was 29 months into our journey. I cannot help but wish we had known about this sooner. My mom could have been stronger,more hopeful, and better equipped to face what was coming.
โก๏ธโก๏ธ๐ธ๐๐๐๐พ๐๐๐๐น ๐พ๐ ๐ธ๐๐๐๐๐๐๐
#alaskastrong #alaskahealth #alaskacancer #AKCancerwarrior #akcommunity #alaskanative #mucosalmelanoma #fightcancer #clinicaltrials #hopeforall #fightforyourrights #fightforyourhealth
Resource limitations should not justify withholding care or information. Patients and families deserve the highest standard of service and complete transparency. It impacts individuals, families, and communities alike.
โข
โข
โข
โข
#patientrights #healthcareforall #transparencyincare #righttoknow #yourhealth #alaskahealthcare
๐ฉ๐๐ช ๐๐ ๐โ๐ค ๐น๐๐ ๐๐๐ฃ๐๐๐ฃ๐ค: ๐๐๐๐ฅ ๐๐ ๐๐๐๐ฃ๐๐๐๐ฉ
This is a copy of my momโs biomarker results, given to us around month 29/30 of her journey. They showed that the immunotherapy she had been receiving for over a year likely would not have worked. Her TMB was low and PD-L1 was not detected, meaning her tumor had few mutations and did not express the protein that helps some immunotherapies work. Reading this was heartbreaking because it confirmed what we had already seen, the treatment wasnโt working. It left us discouraged and cost precious time. If we had known this in the beginning, things could have been different. Instead, she went through treatment that caused side effects, including hypothyroidism, without the benefit we were all hoping for. ๐๐๐๐จ ๐๐จ ๐ฌ๐๐ฎ ๐๐๐ซ๐๐ฃ๐ ๐ฉ๐๐๐จ ๐๐ฃ๐๐ค๐ง๐ข๐๐ฉ๐๐ค๐ฃ ๐๐๐ง๐ก๐ฎ ๐ข๐๐ฉ๐ฉ๐๐ง๐จ ๐จ๐ค ๐ข๐ช๐๐.
โจ๐๐๐๐๐ฃ๐ค๐ฅ๐๐๐๐๐๐ ๐๐ฆ๐๐ ๐ฃ ๐๐๐ฃ๐๐๐ฃ๐ค: ๐๐๐น & โ๐ป-๐๐โจ
When facing cancer, knowledge is power. Two important tests that can guide treatment are Tumor Mutational Burden (TMB) and PD-L1.
๐๐๐ measures how many genetic mutations a tumor has. In a higher TMB can mean the immune system might better recognize the tumor, making certain immunotherapies more effective.
Scale:Low(1-5) Inter(10-19) High (20+)
๐ My momโs result: 5 (Low)
๐๐-๐๐ is a protein some tumors use to hide from the immune system. Knowing PD-L1 levels can help determine whether immunotherapy could be a good option.
But hereโs the key: these results are pieces of a bigger puzzle. Neither TMB nor PD-L1 alone can tell the full story. They need to be considered alongside other genetic markers, tumor type, and overall health.
๐๐ ๐๐๐๐๐๐จ๐๐ช ๐๐
Ask for these tests early. Understanding your results can open doors to treatments, clinical trials, or therapies that might not be considered otherwise.
Knowledge gives you choice and choice is power!
โข
โข
#usahealthcare #alaskahealth #alaska #mucosalmelanoma #juneau #anchorage #fairbanks #alaskanative #alaskan #knowledgeispower
One of the biggest things I wish I had known from the beginning was the importance of finding a support group. While researching success stories from clinical trials, I discovered that one of the survivors of TIL- therapy was running a Facebook support group called Mucosal Warriors. I decided to follow it, and I was astonished to realize that my mom and I were not alone.
When I shared this with her, she was so relieved to know that she wasnโt the only one facing this rare cancer. The group had over 2,000 members, all active posters updating their journeys daily, and new members joining every day. What makes these groups so special is that they bring together patients currently receiving treatment or family members supporting loved ones, providing continuous nationwide support and even international.
Members were seeing doctors at top institutions like Stanford, UCLA, and MD Anderson, so the variety of experiences and insights was incredible. I was able to speak with people who had participated in clinical trials or undergone specific therapies, and I learned about different genetic variants and tests that were being done elsewhere.
This is so important because, if I had known about these groups from the start, I would have realized that certain tests we werenโt receiving were standard requirements at these prestigious hospitals. Access to this kind of knowledge early on can completely change a patientโs treatment path.
๐๐ I SUGGEST ๐๐
Finding a support group for your specific cancer can be a lifeline. My mom found comfort knowing she wasnโt alone in her symptoms or treatment journey, hearing others share the same experiences made a huge difference. It also helped us know what questions to start asking.
๐๐ BE AWARE ๐๐
Her doctor advised against reading things online, saying it was not accurate. But from what I could see after crosschecking and fact checking everything, the information was true and the tests I was asking about were based on what I was learning from these groups.
โข
โข
โข
โข
โข
โข
โข
โข
โข
โข
โข
โข
#support #supportgroups #mucosalmelanoma #melanoma #health #alaska #juneau #anchorage
This is a treatment roadmap I created for my mom before any additional mutations were identified. Her Alaska team later provided me with a primary BRAF genetic result, E586k, from the host tumor. This was tested on the original biopsy conducted in Phoenix prior to her 2023 diagnosis. Unfortunately, this information wasnโt shared with me until 28/30 months into her journey.
๐๐ก๐ข๐ฌ ๐ข๐ฌ ๐ฐ๐ก๐ฒ ๐ข๐ญ ๐ข๐ฌ ๐ฌ๐จ ๐ข๐ฆ๐ฉ๐จ๐ซ๐ญ๐๐ง๐ญ ๐ญ๐จ ๐ซ๐๐๐๐ข๐ฏ๐ ๐ญ๐ก๐ข๐ฌ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฆ ๐ญ๐ก๐ ๐ฌ๐ญ๐๐ซ๐ญ. ๐๐จ๐ฎ ๐จ๐ซ ๐ฒ๐จ๐ฎ๐ซ ๐ฅ๐จ๐ฏ๐๐ ๐จ๐ง๐ ๐๐๐ง ๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐ฅ๐ฅ ๐๐ฏ๐๐ข๐ฅ๐๐๐ฅ๐ ๐จ๐ฉ๐ญ๐ข๐จ๐ง๐ฌ ๐๐ง๐ ๐ง๐๐ฏ๐ข๐ ๐๐ญ๐ ๐ญ๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐ญ๐๐ข๐ฅ๐จ๐ซ๐๐ ๐ญ๐จ ๐ฒ๐จ๐ฎ๐ซ ๐ฌ๐ฉ๐๐๐ข๐๐ข๐ ๐ ๐๐ง๐๐ญ๐ข๐ ๐ฏ๐๐ซ๐ข๐๐ง๐ญ๐ฌ.
โก๏ธ ใ๏ฟฝ๏ผจ๏ผฏ๏ผท ๏ผฉ๏ผด ๏ผท๏ผฏ๏ผฒ๏ผซ๏ผณใ โฌ ๏ธ
The tumor starts with a โhostโ genetic variant, think of it as the host of the party. As treatment begins, new variants can emerge, like new guests joining the party, creating more possibilities for additional treatment options. In my momโs case, her host variant was BRAF E586K (Class 2 ). After receiving immunotherapy and radiation, a new โguestโ emerged: the genetics branched into a CDKN2A variant. For her, treatment options were limited to clinical trials targeting BRAF non v600 or CDKN2A.
โข
โข
โข
โข
โข
โข
โข
โข
โข
โข
โข
โข
#treatment #fightcancer #cancerjourney #cancerwarrior #alaskalife #cancerwarrior #healthcareadvocacy #treatmentroadmap #rosetransparencyact #yourlifeyourchoice #mucosalmelanoma
โจ ๐๐๐๐ฅ ๐ ๐๐๐ ๐๐ ๐ฃ ๐๐ช ๐๐ ๐ โจ
What I did was go through all the clinical trials that looked like they could be good possibilities for my mom based on her genetic variants. I narrowed them down by reading articles about their progress, checking the testing results that were being shared, asking my mucosal warriors group and paying attention to which programs seemed to be moving forward. From there, I focused on the steps that could actually get us closer:
___________________ โก๏ธ ๐๐ก๐๐๐ค ๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐ญ๐ซ๐ข๐๐ฅ๐ฌ: I looked at every trial that seemed like a possible fit and compared them against my momโs case. โก๏ธ ๐๐๐๐ ๐ฎ๐ฉ๐๐๐ญ๐๐ฌ: I dug into articles and reports to see what kind of progress each program was making. โก๏ธ ๐๐จ๐ง๐๐ข๐ซ๐ฆ ๐ซ๐๐ฌ๐ฎ๐ฅ๐ญ๐ฌ: I paid attention to the testing data being released to figure out which ones looked most promising. โก๏ธ ๐๐จ๐ง๐ญ๐๐๐ญ ๐ญ๐ก๐ ๐ฉ๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ: I checked their websites for expanded access options, sometimes thereโs a form or link, emailed the manufacturer direct. Other times it has to come directly from a physician, only found that out after emailing them directly. โก๏ธ ๐๐จ๐ซ๐ค ๐ฐ๐ข๐ญ๐ก ๐ญ๐ก๐ ๐๐จ๐๐ญ๐จ๐ซ: Once I had the information, I brought it to my momโs doctor so we could move forward with the FDAโs Form 3926.
_________________
โจโจMy researchโจโจ
When I contacted the FDA the process was surprisingly easy. I waited only one minute to speak directly with a representative who walked me through the correct steps so I could move forward seamlessly.
From my research I learned that once the pharmaceutical company gives approval the FDA can authorize expanded access within just a few hours. โจ upon urgent usage - your physician can call the phone number or email.
The hardest part isnโt the paperwork. Itโs finding a drug thatโs actually available since access depends on whether the company has enough manufactured and circulating within the trial. ๐
โข
โข
โข
โข
โข
#expandedaccess #health #healthcare #alaska #cancer #fightcancer #rosetransparencyact
๐น How to Advocate for Your Loved One ๐น
Having the right paperwork in place makes it easier to protect your loved oneโs wishes.
โจ Key Steps:
(3 important forms to get notarized at the same time)
โ๏ธ Get documents notarized: many hospitals have a notary on staff.
โ๏ธ Power of Attorney (POA): lets you handle finances/decisions while theyโre alive.
โ๏ธ Health Care Directive (Advance Directive): outlines medical wishes and who can make decisions if they cannot.
โ๏ธ Will: after passing, the will must go through probate court, which gives the executor authority to settle finances, estates, and access medical records.
โ๏ธ Important to Know: โข POA ends when a person passes. โข Only the executor of the will (or court-appointed representative) can handle matters after death.
Preparation = Advocacy ๐
โข
โข
โข
โข
โข
โข
โข
โข
โข
#advocacymatters #patientrights #healthadvocacy #rosetransparencyact #alaskacommunity #alaskahealth #alaskacancer #cancerawarenessalaska #alaskaadvocacy #knowyourrights #familyadvocacy #healthjustice #caregiverstrong #protectyourlovedones
๐ Alaska, letโs take action together!
In 2025, an estimated 3,670 Alaskans will be diagnosed with cancer, and 1,120 will lose their lives. Breast, lung, colorectal, and prostate cancers impact our families and communities every day.
Knowledge is power. The Rose Transparency Act is fighting to make sure patients have clear, timely, and accurate information about their treatment options, clinical trials, and access to potentially life-saving therapies. Early detection and informed choices save lives and every Alaskan deserves that chance. ๐ฟ๐ช Every action counts. ๐ Petition link in bio.
๐ Source: American Cancer Society, 2025
โข
โข
โข
โข
โข
โข
โข
#petition #alaska #alaskan #fightcancer #cancer #rosetransparencyact #alaskanhealthcare #healthcare #alaskannative #communitysupport #alaskaadvocacy #patientempowerment #cancerawareness
๐ Cancer (Malignant Neoplasms) is Alaskaโs #1 cause of death.
In 2023, 1,057 Alaskans died from cancer, about 1 in every 750 people. The age-adjusted death rate was 134.4 per 100,000, slightly down from 2022. (Source: Alaska Vital Statistics 2023 Annual Report, Alaska Health Analytics & Vital Records)
๐ Top cancer deaths in 2023: โข Lung: 220 โข Colorectal: 111 โข Pancreas: 75 โข Breast (women only): 63 โข Prostate: 59 โข Liver & bile ducts: 57
โ๏ธ Why age-adjusted? It levels the playing field so we can compare fairly across time and groups, removing the effects of different age distributions.
โก๏ธ The numbers show progress, but also highlight disparities, especially for Alaska Native people and rural communities.
โจ Awareness, prevention, early detection, and equal access to care save lives.
#alaskahealth #alaskacancer #cancer #numbersdontlie